George Hsiao Selected Research

George Hsiao Research Topics

Disease

9	Ischemia 03/2019 - 09/2002
9	Brain Ischemia (Cerebral Ischemia) 09/2013 - 05/2004
9	Infarction (Infarctions) 02/2012 - 09/2002
8	Brain Injuries (Brain Injury) 09/2013 - 05/2004
7	Neuroinflammatory Diseases 04/2024 - 11/2014
7	Inflammation (Inflammations) 01/2023 - 01/2010
7	Neoplasms (Cancer) 05/2017 - 03/2010
7	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 09/2013 - 09/2005
6	Retinal Degeneration 04/2024 - 01/2017
6	Hypoxia (Hypoxemia) 01/2023 - 03/2007
6	Fibrosis (Cirrhosis) 01/2015 - 06/2009
6	Thrombosis (Thrombus) 10/2005 - 04/2003
5	Asthma (Bronchial Asthma) 05/2022 - 01/2010
4	Respiratory Hypersensitivity 05/2022 - 01/2013
4	Pulmonary Embolism 06/2013 - 04/2003
4	Reperfusion Injury 04/2013 - 09/2002
4	Thromboembolism 12/2010 - 12/2003
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2023 - 06/2020
3	Endotoxemia 06/2019 - 08/2002
3	Cardiovascular Diseases (Cardiovascular Disease) 06/2013 - 01/2009
3	Atherosclerosis 04/2011 - 08/2003
2	Ganglion Cysts (Ganglion) 01/2023 - 10/2015
2	Sepsis (Septicemia) 06/2019 - 06/2017
2	Uveitis 03/2019 - 01/2018
2	Fibrosarcoma 03/2018 - 02/2012
2	Lung Neoplasms (Lung Cancer) 04/2014 - 04/2012
2	Chondrosarcoma 04/2013 - 05/2011
2	Ischemic Stroke 02/2012 - 04/2011
2	Vascular Diseases (Vascular Disease) 12/2011 - 04/2006
2	Neoplasm Metastasis (Metastasis) 12/2011 - 05/2011
2	Hypertension (High Blood Pressure) 01/2009 - 01/2004
2	Hypotension (Low Blood Pressure) 01/2009 - 08/2002
2	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 07/2008 - 02/2008
2	Seizures (Absence Seizure) 09/2007 - 01/2004
2	Ventricular Fibrillation 09/2006 - 09/2002
2	Myocardial Ischemia (Ischemic Heart Diseases) 09/2006 - 09/2002
2	Shock 04/2003 - 08/2002
1	Macular Degeneration (Age-Related Maculopathy) 01/2023
1	Macular Edema 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2023
1	Blindness (Hysterical Blindness) 01/2023

Drug/Important Bio-Agent (IBA)

11	Matrix Metalloproteinases (MMPs)IBA 06/2019 - 01/2009
9	Retinaldehyde (Retinal)IBA 02/2023 - 01/2017
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2015 - 03/2007
8	Free RadicalsIBA 02/2012 - 08/2002
7	CytokinesIBA 05/2022 - 01/2009
6	Neuroprotective AgentsIBA 01/2019 - 04/2006
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 08/2003
6	Caspase 3 (Caspase-3)IBA 02/2012 - 03/2007
5	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 02/2012 - 04/2006
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 01/2013
4	OvalbuminIBA 05/2022 - 01/2010
4	Immunoglobulin E (IgE)IBA 05/2022 - 01/2013
4	LipopolysaccharidesIBA 06/2019 - 08/2002
4	Adenosine Diphosphate (ADP)IBA 06/2013 - 04/2003
4	Histone Deacetylase InhibitorsIBA 04/2012 - 05/2011
4	Fluorescein (Funduscein)FDA LinkGeneric 10/2005 - 05/2003
3	2,3,7,7a- tetrahydro- 3- hydroxy- 7- methyl- 2- (prop- 1- en- 1- yl)- 5H- furo(3,4- b)pyran- 5- oneIBA 02/2023 - 01/2018
3	Retinal Pigments (Pigments, Visual)IBA 01/2023 - 01/2018
3	Interleukin-10 (Interleukin 10)IBA 05/2022 - 01/2010
3	Matrix Metalloproteinase 9 (Gelatinase B)IBA 06/2019 - 06/2017
3	Histone Deacetylases (Histone Deacetylase)IBA 02/2012 - 05/2011
3	theasinensin AIBA 02/2012 - 05/2011
3	Therapeutic UsesIBA 04/2011 - 05/2004
3	SolventsIBA 04/2011 - 05/2004
3	tetramethylpyrazineIBA 03/2007 - 04/2006
3	AntioxidantsIBA 03/2007 - 04/2003
2	sodium iodateIBA 02/2023 - 01/2023
2	LipofuscinIBA 01/2023 - 04/2019
2	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2023 - 05/2022
2	Interleukin-5 (Interleukin 5)IBA 05/2022 - 01/2013
2	Interleukin-13IBA 05/2022 - 01/2013
2	ethyl acetateIBA 03/2018 - 01/2017
2	Anti-Allergic Agents (Antiallergic Agents)IBA 10/2017 - 01/2016
2	imperatorinIBA 10/2017 - 01/2016
2	Coloring Agents (Dyes)IBA 10/2015 - 08/2002
2	SurvivinIBA 04/2014 - 02/2012
2	andrographolideIBA 09/2013 - 12/2011
2	Midazolam (Versed)FDA LinkGeneric 04/2013 - 03/2004
2	Plasminogen Activator Inhibitor 1IBA 04/2012 - 06/2009
2	trichostatin A (A 300)IBA 02/2012 - 05/2011
2	sesamolIBA 05/2011 - 12/2010
2	Messenger RNA (mRNA)IBA 01/2009 - 03/2007
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2009 - 08/2002
2	Amyloid beta-PeptidesIBA 07/2008 - 02/2008
2	3-nitrotyrosineIBA 03/2007 - 04/2006
2	Oxygen (Dioxygen)IBA 09/2006 - 09/2002
2	Dihydrotachysterol (AT 10)IBA 04/2006 - 09/2002
2	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 10/2005 - 06/2005
2	LycopeneIBA 10/2005 - 05/2004
2	Magnesium Sulfate (Sulfate, Magnesium)FDA LinkGeneric 01/2004 - 05/2003
1	Antiglaucoma AgentsIBA 04/2024
1	N-Methylaspartate (NMDA)IBA 04/2024
1	Advanced Glycation End ProductsIBA 01/2023
1	beta-(5-hydroxy-2-pyridyl)alanineIBA 01/2023
1	Metformin (Glucophage)FDA LinkGeneric 01/2023
1	Pyruvaldehyde (Methylglyoxal)IBA 01/2023

Therapy/Procedure

4	Therapeutics 01/2023 - 04/2011
3	Oral Administration 05/2022 - 01/2011
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2017 - 01/2011